Falvo Michael J, Earhart Gammon M
Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO 63108, USA.
Arch Phys Med Rehabil. 2009 Jun;90(6):1004-8. doi: 10.1016/j.apmr.2008.12.018.
To determine the six-minute walk distance (6MWD) in subjects with Parkinson disease (PD) and to determine the impairments that contribute to walking capacity.
Descriptive cross-sectional study of subjects with PD.
University laboratory.
Subjects with PD (N=75; 65.0+/-9.5y) of mild to moderate severity, as defined by an average Hoehn and Yahr (HY) rating of 2.0+/-0.4 and Unified Parkinson Disease Rating Scale (UPDRS) motor score of 27+/-8.9, were tested on medication.
Not applicable.
Subjects were administered the motor subsection of the UPDRS and completed the following tests: Berg Balance Scale (BBS), Timed Up & Go (TUG), and six-minute walk test. In addition, they also provided self-reports of freezing of gait and number of falls in the past 6 months.
The average 6MWD was 391.6+/-99.9 m. All of the aforementioned tests, with the exception of fall number (P=.07), correlated significantly with 6MWD (r range, -.64 to .55). By using a hierarchical regression model, we entered age, HY, and UPDRS motor score into the first block (ie, set of independent variables) to represent parkinsonian characteristics, which explained a significant amount of variability in 6MWD (R2=.196, P<.001). The second block entered (eg, functional measures scores, self-reports) explained a significant amount of additional variability (R2 change=.355, P<.001). The TUG, BBS, and number of falls contributed independently in the presence of all independent variables.
The 6MWD in subjects with PD is explained in part by disease-specific characteristics and perhaps to a greater extent by impaired balance and predisposition to falling. Training targeted at improving balance and reducing falling risk factors may increase 6MWD (ie, walking capacity) in subjects with PD.
确定帕金森病(PD)患者的六分钟步行距离(6MWD),并确定影响步行能力的损伤因素。
对PD患者进行描述性横断面研究。
大学实验室。
轻度至中度严重程度的PD患者(N = 75;年龄65.0±9.5岁),平均Hoehn和Yahr(HY)分级为2.0±0.4,统一帕金森病评定量表(UPDRS)运动评分27±8.9,均在服药状态下接受测试。
不适用。
对受试者进行UPDRS运动部分评估,并完成以下测试:伯格平衡量表(BBS)、定时起立行走测试(TUG)和六分钟步行测试。此外,他们还提供了过去6个月内步态冻结和跌倒次数的自我报告。
平均6MWD为391.6±99.9米。除跌倒次数外(P = 0.07),上述所有测试均与6MWD显著相关(r范围为 - 0.64至0.55)。通过使用分层回归模型,我们将年龄、HY和UPDRS运动评分纳入第一个模块(即自变量集)以代表帕金森病特征,这解释了6MWD中很大一部分变异性(R2 = 0.196,P < 0.001)。第二个模块纳入的变量(如功能测量评分、自我报告)解释了大量额外变异性(R2变化 = 0.355,P < 0.001)。在所有自变量存在的情况下,TUG、BBS和跌倒次数各自独立起作用。
PD患者的6MWD部分由疾病特异性特征解释,可能在更大程度上由平衡受损和跌倒倾向所解释。针对改善平衡和降低跌倒风险因素的训练可能会增加PD患者的6MWD(即步行能力)。